(NOW) Stock Price prediction EPIRUS Biopharmaceuticals Inc in 2027

Updated: 2024-02-06

Updated Stock Price EPIRUS Biopharmaceuticals Inc plc (EPIRUS Biopharmaceuticals Inc)

EPRSQ-USD EPIRUS Biopharmaceuticals Inc - USD Dollar
0.0000010000 0% (0)

You are interested in stocks EPIRUS Biopharmaceuticals Inc plc and you would like to buy it, and maybe you already have it in your portfolio? If so, on this page you will find helpful information about the dynamics of the share price EPIRUS Biopharmaceuticals Inc in 2027 How much will the share be worth EPIRUS Biopharmaceuticals Inc in 2027?

Stock historical and prediction chart EPIRUS Biopharmaceuticals Inc

The chart below shows the historical price fluctuation of the stock EPIRUS Biopharmaceuticals Inc and a prediction chart for the next month. For simplicity, costs are divided into colors. Prediction prices include an optimistic prediction, a pessimistic prediction and a weighted average of the best prediction. Detailed share price values EPIRUS Biopharmaceuticals Inc can be found in the table below.

Long-term predictions by year.

EPIRUS Biopharmaceuticals Inc monthly stock prediction for 2027

Data Target Opt. Pes. Vol. %
Jan 0.00091 0.0011 0.00066 66.67%
Feb 0.00056 0.00083 0.00026 219.23%
Mar 0.00099 0.0012 0.00078 53.85%
Apr 0.00139 0.00164 0.00119 37.82%
May 0.00148 0.00167 0.00127 31.5%
Jun 0.00134 0.00159 0.00107 48.6%
Jul 0.00123 0.0015 0.00096 56.25%
Aug 0.00105 0.00124 0.00081 53.09%
Sep 0.00121 0.00141 0.00093 51.61%
Oct 0.00136 0.00157 0.00109 44.04%
Fox 0.00111 0.00134 0.00091 47.25%
Dec 0.00115 0.00138 0.00089 55.06%

Prediction EPIRUS Biopharmaceuticals Inc for this year

Stock predict EPIRUS Biopharmaceuticals Inc for 01-2027.

Uptrend prediction for this month with optimal price target at $0.00091.

Pessimistic: $0.00066.

Optimistic: $0.0011.

Stock predict EPIRUS Biopharmaceuticals Inc for 02-2027.

Uptrend prediction for this month with optimal price target at $0.00056.

Pessimistic: $0.00026.

Optimistic: $0.00083.

Stock predict EPIRUS Biopharmaceuticals Inc for 03-2027.

Uptrend prediction for this month with optimal price target at $0.00099.

Pessimistic: $0.00078.

Optimistic: $0.0012.

Stock predict EPIRUS Biopharmaceuticals Inc for 04-2027.

Uptrend prediction for this month with optimal price target at $0.00139.

Pessimistic: $0.00119.

Optimistic: $0.00164.

Stock predict EPIRUS Biopharmaceuticals Inc for 05-2027.

Uptrend prediction for this month with optimal price target at $0.00148.

Pessimistic: $0.00127.

Optimistic: $0.00167.

Info

When to take profits on stocks EPIRUS Biopharmaceuticals Inc? When to take a loss on stocks EPIRUS Biopharmaceuticals Inc? What are analyst prediction for the stock EPIRUS Biopharmaceuticals Inc? What does the future hold for stocks EPIRUS Biopharmaceuticals Inc?

We predict stock results EPIRUS Biopharmaceuticals Inc using neural networks based on historical data about shares EPIRUS Biopharmaceuticals Inc. In addition, the Prediction uses technical analysis tools and takes into account geopolitical factors and news from around the world.

The goal is to find an investment strategy that will provide above-average returns in all market conditions. Our predict EPRSQ is updated daily to help investors know whether now is a good time to buy or sell stocks EPRSQ.

Stock prediction results EPIRUS Biopharmaceuticals Inc are presented in the form of charts, tables and text information divided into time intervals.

The final prices of instruments at the close of the previous trading day are a signal to revise the stock prediction EPIRUS Biopharmaceuticals Inc. It happens once a day.

Statement

All prediction data on the website is provided for informational purposes for the use of neural predicting tools in the financial market and does not constitute a solicitation for trading, nor is it a trading signal. By using prediction data, the investor assumes all financial risk. The EURUSD.site website is not responsible for the loss of your money on the stock exchange as a result of using the information contained on the website.